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Sammendrag (summary in Norwegian) 
Infeksiøs pankreas nekrose (IPN) er en smittsom sykdom som rammer salmonider i tidlige 
livsstadier. Økonomiske tap som følge av sykdommen er et problem for kommersielle 
oppdrettere av laks, ørret og røye over store deler av verden. Viruset som forårsaker denne 
sykdommen, infeksiøst pankreas nekrose virus (IPNV), er et dobbeltrådig RNA (dsRNA) 
virus i familien Birnaviridae. Viruset har en ikosahedrisk kapsid-struktur, omtrent 60 nm i 
diameter, og er uten en ytre kappe. Virusgenomet består av to dsRNA segmenter, kalt 
segment A og B, som koder for fem proteiner, VP1-VP5. VP1 er den virale RNA-
polymerasen som kodes av Segment B. Dette proteinet finnes i to former – fritt eller bundet til 
dsRNA. På segment A er det en stor åpen leseramme som koder for et polyprotein som 
kløyves av virusets egen protease, VP4, for å danne strukturproteinene VP2 og VP3. IPNV 
kapsidet, som er virusets ytre struktur, er bygd opp av VP2. I tillegg har segment A en liten, 
alternativ leseramme som koder for VP5, et ikke-strukturelt protein med hittil udefinerte 
egenskaper.  
Dagens vaksiner gir en begrenset beskyttelse mot IPNV. For å optimalisere effekten av 
vaksinering, er det viktig å få en bedre forståelse for hvordan spesifikke faktorer i virus og 
vert interagerer med hverandre under en infeksjon. I denne avhandlingen beskrives fysiske 
interaksjoner mellom ulike virusproteiner og betydningen av disse diskuteres. Ved å benytte 
nye molekylærbiologiske metoder har vi vist at VP3 har en sentral rolle i viruspartikkelen 
fordi det binder seg både til andre VP3 proteiner, til VP1 polymerasen og til virusgenomet. 
De ulike domenene for binding er kartlagt.  
Det er også viktig å kartlegge hvordan verten forsvarer seg mot virusinfeksjoner. Dette er lite 
studert hos fisk. Interferoner er alarmproteiner som produseres når virus infiserer mennesker 
og dyr.  Dette forsvarssystemet slås på av virusets arvestoff (RNA) og kan stoppe videre 
invasjon av viruset. Det finnes flere typer IFN. Type I IFN (IFNα/β) er det som primært er 
assosiert med direkte antiviral aktivitet, mens type II (IFNγ) i tillegg har mer spesialiserte 
funksjoner knyttet til ervervet immunitet. Gjennom evolusjonen har mange virus utviklet 
strategier for å unngå vertens forsvar mot virus. Dette gjelder også for IPNV. Tilsetning av 
IFN gjør uinfiserte celler svært motstandsdyktige mot IPNV. Da evner ikke viruset å 
gjennomføre egen proteinsyntese og dannelsen av nye viruspartikler blokkeres. Hos celler 
som er infisert med IPNV før de behandles med IFN, klarer IPNV ”å slå tilbake” slik at 
uttrykket av antivirale gener i vertscella dempes. Det ser altså ut til at viruset har strategier for 
 - 6 - 
å hemme signalveien nedstrøms for IFN, den såkalte JAK/STAT signalveien. Vi foreslår at 
VP4 og VP5 er kandidater til denne ”motstandsfunksjonen”.  
STAT1 er et viktig molekyl som aktiveres av IFN og bidrar til oppregulering av antivirale 
gener. I dette arbeidet har vi klonet STAT1 fra atlantisk laks og vist at i likhet med pattedyr 
vil laksens STAT1 bli aktivert i IFN-stimulerte celler. Vi viser at også laksens STAT1 har et 
konservert tyrosin som fosforyleres på signal fra både type I og type II IFN og transporteres 
fra cytoplasma inn til cellekjernen på signal fra IFNγ. I tillegg har vi sett at STAT1 danner 
dimerer med andre STAT1 molekyler. Vi har ikke funnet noen direkte interaksjon mellom 
IPN virus-proteinene og STAT1 som kan forklare virusets evne til å hemme IFN-responsen. 
Vi vil arbeide videre med å kartlegge hvilke molekyler som er involvert i denne effekten
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Introduction 
Viruses are intracellular, parasitic particles that depend on the host cells they infect in order to 
reproduce. Viruses consist of either a single-stranded or a double-stranded DNA or RNA 
genome in addition to a protective protein coat. Viruses exist in the air, soil and water and 
infect all cellular life. As protection against the dozens of viruses that attack, vertebrates have 
two major ways to defend themselves: a general antiviral protection provided mainly by small 
molecules called interferons and specific mechanisms like antibody production and killing of 
virus-infected cells by cytotoxic T cells. Most antibodies give lifelong immunity, but it takes 
days or weeks to produce them, and each type of antibody is effective against only one type of 
virus. Interferon production is faster, and occurs within a few hours of exposure, but still it is 
not fast enough to keep many invading viruses from multiplying in millions of cells and 
causing severe illness. Interferons are effective against the whole catalogue of viruses, but its 
protection may last only a short period. Thus the immune system is a collection of biological 
processes within an organism that protects against disease by identifying and fighting 
pathogens in clever ways. 
Infectious pancreatic necrosis (IPN) 
History of IPN 
Infectious pancreatic necrosis (IPN), previously called acute catarrhal enteritis, is a severe, 
contagious disease mainly occurring among salmonids. The disease was first described in the 
United States in 1941 (M'Gonigle, 1941), but was not detected in Norway until 1971. Early 
descriptions of the occurrence of the disease were usually connected to fry in the early fresh-
water phase and with high mortality numbers (Wood et al., 1955). Later, from the mid-1980s, 
outbreaks have often been reported to occur during transfer from fresh- to sea-water 
(smoltification) and increasingly, also among adult fish.  
Pathology of IPN 
Pathological changes include abnormal, whirling swimming motion, darkening pigmentation, 
pronounced distended abdomen, necrotic tissue in pancreas, milky mucus in stomach and 
anterior intestine, long thin whitish faecal casts and pale gills, spleen, kidney, liver and heart 
(OIE, 2000). 
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Epidemiology of IPN 
The causative agent is the IPN virus (IPNV) which has a history as one of the major loss 
factors in Norwegian and international (salmonid) aquaculture. IPNV has been isolated from 
economically important salmonid species such as trout, salmon, whitefish, and grayling, and 
additionally from many other fish species including, herring, sole, halibut, cod, saithe, eel, 
bass, pike, perch, carp, cichlids and lamprey (Noga, 2000). Some of these are also potential 
aquaculture species. Aquatic invertebrates such as oysters, crabs and even trematodes have 
also been found to be infected with IPNV. To these nonsalmonid species IPNV is only 
occasionally being pathogenic, meaning that in a clinical aspect these species function as 
carriers or reservoirs of virus isolates (Noga, 2000). IPNV was for the first time, as the first 
fish pathogen, isolated and propagated in cell culture in 1958 (Wolf et al., 1958) and has later 
been extensively studied. As Atlantic salmon aquaculture has dramatically expanded, the 
disease has emerged worldwide and is now recognized to be the economically most important 
disease in salmon production in the European Union and in Norway (Roberts and Pearson, 
2005). A comprehensive survey of  more than 30 000 fish comprising 37 species in the 
Scottish marine environment has been undertaken by Wallace et al. (2008) in order to 
investigate the prevalence of IPNV in wild fish near clinically infected Atlantic salmon farms. 
This study shows that there is a localized small increase in the prevalence of IPNV in wild 
marine fish caught near the farms. Fortyfive isolations of IPNV were made from nine 
different species. The results suggest that farms do act as a source of infection to wild fish; 
however, there is also evidence that IPNV is endemic in wild marine fish. Wild fish reservoirs 
are, however, probably not a major factor for infection of marine salmon farms (Murray, 
2006). In addition to horizontal transmission, IPNV has been shown to be vertically 
transmitted through the germline from parent to progeny in rainbow trout (Dorson and Torchy, 
1985). This process is also strongly suspected to occur in Atlantic salmon, though it has not 
yet been proven experimentally (Smail and Munro, 2008). 
Prevention and control of IPN 
In general, viral disease can largely be prevented by rearing fish in a good environment, with 
good nutrition, a minimum of stress, and isolated from sources of infectious agents. 
Avoidance of pathogens requires good sanitation at the fish farms and is best achieved with a 
pathogen-free water supply, the use of certified pathogen-free stocks, and strict biosecurity. 
Development of disease also depends on a complex set of factors such as interactions among 
the host, the pathogen, and the environment. Host factors include the species, size or age, 
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strain or stock, immune status, and general physiological condition. For the pathogen, factors 
include the concentration of infectious particles present in water, their physiological 
properties and the virulence of the strain. The difference between apparent health and disease 
typically depends on the balance between the pathogen and the host, and that balance is 
greatly influenced by environmental factors such as temperature and water chemistry. There is 
no reliable treatment for IPN, therefore disinfection and quarantine are the best methods of 
controlling IPN outbreaks.  
Screening 
Broodstock testing is very important for fish farmers to limit spread of disease. Currently, 
screening for diseases is based upon isolation of the virus in tissue culture followed by 
immunological identification. Additionally, reverse transcription-polymerase chain reaction 
(RT-PCR) protocols for IPNV have been developed (Blake et al., 1995; Lopez-Lastra et al., 
1994; Taksdal et al., 2001). A very high proportion of macrophages in kidney tissue and 
blood leucocytes from IPNV-carriers are infected with IPNV (Munro et al., 2006). Thus, 
destructive kidney sampling followed by PCR and cell-based viral titration is the most 
sensitive method for detecting Atlantic salmon broodfish carrying IPNV (Munro and Ellis, 
2008). New, diagnostic methods for rapid and reliable detection and identification of IPNV, 
based on RT-PCR-ELISA (Milne et al., 2006) and reverse transcription loop-mediated 
isothermal amplification (RT-LAMP) technology (Soliman et al., 2009) have been proposed. 
Offering non-lethal detection methods will be useful and more cost-efficient to the industry. 
Sampling based on culturing of adherent blood moncytes or gonadal fluids are less sensitive, 
but beneficial in that they are non-lethal detection methods. A highly sensitive and specific 
real-time RT-PCR assay has recently been developed for the detection and quantitation of 
IPNV in rainbow trout.  The viral protease, VP4, can reliably be detected down to 10 RNA 
copies in spleen and head kidney as early as 24 h post-challenge, and non-lethal sampling 
from pectoral fin gives the same results (Bowers et al., 2008). The source of the virus in the 
case of vertical transmission of IPN is likely to be the sperm of carrier males or female carrier 
eggs, meaning that this method is also beneficial to facilitate investigations into the possibility 
of vertical transmission of IPNV in Atlantic salmon (Smail and Munro, 2008).  
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Table 1. Outbreaks of IPN, ISA, PD and VHS reported in Norwegian fish farms in the years 2002-2008 (Report 
on the health status in Norwegian fish farms 2008, by the National Veterinary Institute). 
 2002 2003 2004 2005 2006 2007 2008 
IPN 174 178 172 208 207 165 158 
ISA 12 8 16 11 4 7 7 
PD 14 22 43 45 58 98 108 
VHS 0 0 0 0 0 3 2 
 
Vaccines 
IPN vaccines have been developed and a vaccination program has been ongoing since 1995, 
although the efficacy of the current vaccines is debatable. In Norway, 85% of smolts are given 
the vaccine; still, more outbreaks are reported due to IPNV than for any other fish pathogen 
every year. In 2008 158 fish farms along the coast had outbreaks of IPN (www.ssb.no) (Table 
1). The vaccines against IPNV currently commercially available in Norway are multivalent 
bacterin oil-adjuvanted vaccines based on a recombinantly expressed subunit of the IPN virus 
(Frost and Ness, 1997) or formalin inactivated IPNV (Pharmaq, Novartis). No live attenuated 
vaccines or DNA vaccines are currently licensed in Europe, but one DNA vaccine against the 
rhabdovirus infectious hematopoietic necrosis virus (IHNV) has been licensed in Canada 
(July 2005, Apex-IHN, Novartis) after controlled field trials (Salonius et al., 2007). A DNA 
vaccine which is protective against another rhabdovirus, VHSV (Lorenzen and LaPatra, 2005), 
is currently being evaluated for use in Denmark.  Survivors of IPNV infection usually become 
persistently infected and thereby serve as pathogen reservoirs (McAllister et al., 1987). IPNV 
is also strikingly environmentally persistent and can survive for days and months in water and 
even in air (Toranzo and Hetrick, 1982). It has also been shown that prophylaxis against 
IHNV in rainbow trout is actually induced by pre-exposure to a non-lethal infection with 
IPNV, probably due to induction of interferons and thereby establishment of an antiviral state 
(Kim et al., 2009; Saint-Jean and Pérez-Prieto, 2007). 
Genetic selection by breeding 
Vaccine trals with IPNV have shown that the genetic constitution of the fish has a strong 
influence on the protective outcome of the vaccine (Ramstad and Midtlyng, 2008). Although 
this variability has provided a problem in achieving high and consistent control-fish 
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mortalities in challenges for vaccine testing, the hereditable, genetic resistance to IPNV can 
be successfully used in Atlantic salmon family breeding schemes. Genetic information on 
family differences in resistance has been collected from a large challenge study with IPNV in 
Atlantic salmon post-smolts (Guy et al., 2006). Using a genome-wide scan, the most 
significant quantitative trait locus (QTL) found was mapped to LG 21. QTLs are stretches of 
DNA that are closely linked to the genes that underlie the inheritance of a phenotypic 
characteristic in question. This knowledge may be developed for use in selection for breeding 
strains of Atlantic salmon with greater resistance to IPN (Houston et al., 2008). One should be 
avare though, that intensive selection of one attribute might cause loss of other desired traits. 
IPNV 
Classification 
IPNV is classified as an Aquabirnavirus within the family Birnaviridae. Other members are 
the infectious bursal disease virus (IBDV), an Avibirnavirus that infects young chickens, and 
drosophila X virus (DXV) of the genus Entomobirnavirus, which is infectious to the fruitfly 
Drosophila melanogaster (Dobos 1995). In addition to IPNV, the genus Aquabirnavirus 
includes Yellowtail ascites virus, Tellina virus and a group of unclassified Aquabirnaviruses, 
including marine birnavirus and Japanese aquabirnavirus (NCBI taxonomy browser). Most 
knowledge about the birnaviruses is based on studies of IBDV and IPNV (Muller et al., 2003; 
Rodriguez Saint-Jean et al., 2003). 
IPNV genome and proteins 
The common feature for members of the Birnaviridae family is their bi-segmented dsRNA 
genome (designated segment A and B) that is enclosed in a non-enveloped single-shelled 
icosahedral particle of 60 to 70 nm in diameter (Figure 1). VP1, the viral RNA-dependent 
RNA polymerase (RdRp) encoded by segment B, is the largest of the viral proteins with a 
mass of 94 kDa which comprices only 4% of the virion. VP1 is found in both free and 
genome-linked forms in the virion. The genome-linked form, VPg, is linked by a 
phosphodiester bond to the 5’-end of both genome segments (Dobos, 1995). The larger of the 
two segments, segment A (3.1 kb), encodes a polyprotein which is cotranslationally cleaved 
by the viral encoded serine-lysine protease (VP4) releasing proteins pVP2 and VP3 (Duncan 
and Dobos, 1986; Duncan et al., 1987). pVP2 is further processed most efficiently by host cell 
proteases to form the mature outer capsid protein VP2 (Magyar and Dobos, 1994b), which 
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makes up about 60% of the virion (Dobos, 1995) and contains the antigenic region 
responsible for induction of neutralizing antibodies in the host (Heppell et al., 1995). The 
viral subunit vaccine currently available in Norway is based on the epitope-containing amino 
acids 86-210 of VP2 recombinantly expressed in E. coli (Christie, 1997; Frost et al., 1995; 
Frost and Ness, 1997). VP3 is an internal structural protein which is the protein present in 
highest numbers in the virion, although with a smaller size than VP2 (27 kDa vs 49 kDa) it 
constitutes only 34% of the virion (Dobos, 1995). In IBDV an interaction between VP3 and 
VP1 has been reported to be important for assembly of the virus particle. IBDV VP3 also 
interacts with itself and binds to viral RNA predicting its function to be a multitasking 
organizer (Maraver et al., 2003; Tacken et al., 2002). As mentioned, IPNV VP4 is the viral 
protease critical for autocleavage of the polyprotein encoded by segment A. Two amino acid 
residues, serine 633 and lysine 674 are critical for its cleavage activity (Petit et al., 2000). 
These residues are conserved across the Lon family of proteases (Birghan et al., 2000). VP4 
was recently crystallized, and four substrate binding pockets identified, providing insights 
into the catalytic mechanism of this protease (Lee et al., 2007). Segment A contains a second, 
smaller open reading frame in the 5’ end, which encodes the non-structural protein, VP5 
(Magyar and Dobos, 1994a), with so far undefined properties. Hong et al.(2002) have 
suggested an anti-apoptotic effect of VP5, based on its homology to the anti-apoptotic protein 
Bcl-2, and enhanced cell viability by over-expression of VP5 in vitro. This property is 
contradicted by Santi et al. (2005a), who fail to show antiapoptotic activity of VP5. These 
conflicting results are suggested to be due to substitutions of amino acids in the domain being 
functionally important for the anti-apoptotic effect of the protein. Later, IPNV has been 
shown to activate the apoptosis-regulating transcription factor NF-κB, possibly through the 
tyrosine kinase pathway (Hong et al., 2008).  There is extensive homology between the 
noncoding sequences of segment A and B which is suggested to be important for polymerase 
recognition, translation initiation and possibly genome packaging (Dobos, 1995).  
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Figure 1: A. The two genomic segments of IPNV encode 5 proteins. B. Electronmicrography of IPNV particles 
(from (Villanueva et al., 2004)).  C. Model of IBDV. D. Table showing the molecular weight (Mw) in kilo 
Daltons (kDa) and the best characterized function of each viral protein.  
Viral replication  
The full IPNV replication cycle takes about 24 h at 15oC, or 16-20 h at 22oC in Chinook 
salmon embryo (CHSE-214) cells (Dobos, 1995; Lannan et al., 1984). IPNV, like other 
nonenveloped animal viruses, seems to enter the host cells by receptor mediated endocytosis 
after specific attachment to CHSE-214 cells (de las Heras et al., 2008; Granzow et al., 1997; 
Kuznar et al., 1995) (Figure 2). Specific attachment of IPNV to other  fish cell types (BF-2 
and EPC) is also observed (de las Heras et al., 2008). VP2 is suggested to be the cell 
attachment protein (Dobos, 1995), but no cellular recognition molecule has been identified. 
After cell entry, the IPNV may proceed directly with transcription as uncoating is not 
necessary and the RdRp is active without further proteolytic treatment. The replication cycle 
takes place in the cytoplasm (Cohen, 1975). Transcription is primed by VP1 binding to RNA 
followed by a semi-conservative strand-displacement on the positive RNA-strand (Dobos, 
1995). Recent studies have shown that the negative RNA strand is the template for the 
genomic replication (Cortés-San Martin et al., In press). Viral mRNA can be detected as early 
as 4-6 h post infection (p.i.), and shortly after, virus specific polypeptides occur. The 
synthesis of viral RNA reaches its peak level 8-10 h p.i. (Cortés-San Martin et al., In press; 
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Dobos, 1995). During a single replicative cycle, two 
different kinds of particles are formed; one larger, 
uninfectious particle termed provirion, where the capsid is 
composed of both mature and immature viral polypeptides, 
the other is the mature, infectious virion (Villanueva et al., 
2004). It is uncertain how the viral progeny is released from 
the cells, as no exocytosis or other virus releasing 
mechanisms have been observed (Granzow et al., 1997). 
Figure 2: IPNV enters into a rainbow trout gonad (RTG-2) cell by 




The mortality of IPN outbreaks in Atlantic salmon farming varies considerably. Mortality 
rates ranging from 6 – 90% are reported from field outbreaks (Santi et al., 2004). The viral 
genome is under strong selection pressure exerted by the host immune system. The molecular 
basis for the variation in virulence has been studied by genomic sequencing of IPNV isolates 
collected from outbreaks of the disease in Norwegian fish farms. Differences are revealed in 
the genomic sequences of VP2 (Blake et al., 2001; Santi et al., 2004), VP3 and VP5 ((Santi et 
al., 2004) own unpublished data). Certain amino acids in the sequence of VP2 have proven to 
be important factors in the determination of the virulence of a strain. Threonin (T), alanin (A) 
and T in positions 217, 221 and 247, respectively, gives a highly virulent virus. In low 
virulence strains these positions are exchanged with proline (P)AT (Santi et al., 2004). The 
amino acid residue 221 of VP2 is in addition identified as a possible persistence determinant. 
Strains encoding threonine at this position establish a carrier state in almost 100% of the fish, 
while fish challenged with strains encoding alanine at this position either cleared the infection, 
or became carriers of a virus with a mutation in VP2 residue 221 (Song et al., 2005). Also 
VP5 has been suggested as a virulence factor. However, a study applying recombinant, 
truncated variants of VP5 induced more than 80% cumulative mortality excluding VP5 as an 
important virulence factor in IPNV infection (Santi et al., 2005b). VP5 has also been shown to 
be dispensable for the establishment of a carrier state (Santi et al., 2005b). Interestingly, IPNV 
cause viral interference to replication of IHNV, which show significant reduction in titers 
when co-infected with IPNV. The mechanisms through which IPNV interferes with IHNV 
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replication are poorly understood and might be due to competition for viral receptors, 
unspecific activation of immune responses or accumulation of dsRNA (de las Heras et al., 
2008). Other factors may apply to the virus’s ability to replicate in host cells. Further genomic 
analyses linked to the virus’s virulence in addition to comparative studies of virulent and non-
virulent isolates and their effect on host gene-expression (i.e. microarrays and RT q-PCR) can 
elucidate possible genetic traits that lead to virulence. The roles of the individual virus 
proteins connected to protection, persistence and virulence are still not properly resolved. 
Interferons 
Interferon (IFN) was discovered more than 50 years ago as an agent that inhibited the 
replication of influenza virus (Isaacs and Lindenmann, 1957). The IFN family of cytokines is 
now recognized as key components of the innate immune system. Accordingly, IFNs are 
currently being used therapeutically, with antiviral effects in the treatment of some viral 
diseases and they also show effectiveness in suppressing certain cancers (Borden et al., 2007). 
There are three types of IFN described in mammals (type I-III). Animal viral infection 
directly induces type I IFN (IFN α/β/κ/δ/ε/τ/ω/ζ) or the recently described type III IFN 
(IFNλ1/2/3) synthesis (Onoguchi et al., 2007). The synthesized and secreted cytokines in turn 
induce transcription of antiviral genes through a signaling cascade as part of the “first-wave” 
immune response of the innate immune system, acting within hours, whereas adaptive 
immune responses like antibody production takes days (Samuel, 2001). Type II IFN has a 
single member; IFNγ which is secreted mainly by activated T cells and natural killer (NK) 
cells, rather than in direct response to viral infection. Although IFNs have crucial roles in 
regulating innate immune responses, they are also factors in adaptive immunity. 
Ways to identify “the bad guys”; IFN induction/production 
There are several ways in which a cell can recognize an infectious agent, and multiple 
signaling pathways that can lead to induction of IFNs (Randall and Goodbourn, 2008). 
Through surface-bound receptors and receptors localized in endosomes or in the cytosol, the 
host cells can respond to approaching pathogens (Figure 3). Toll-like receptors (TLRs) are a 
type of pattern recognition receptors (PRRs) which recognize specific pathogen-associated 
molecular patterns (PAMPs) distinguishable from host molecules. The majority of TLRs are 
transmembrane proteins with a leucine-rich ectodomain and a conserved intracellular domain 
known as the Toll/interleukin-1 receptor (TIR) domain. These domains trigger a series of 
mechanisms leading to the synthesis and secretion of cytokines and activation of other host 
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defense programs that are crucial to the development of innate or adaptative immune 
responses. So far 13 mammalian TLRs have been identified (Kawai and Akira, 2009). Toll-
like receptors bind and become activated by different ligands. TLR3 transduces its signal in 
response to dsRNA, either viral or synthetic (poly I:C), which are known to be efficient 
inducers of IFN-α/β (Alexopoulou et al., 2001). Mammalian TLR3 has a wide tissue 
distribution and is localized either in the endosomal membrane or on the cell surface (Randall 
and Goodbourn, 2008). This signal transduction is complex and 
 
Figure 3. Recognition of viral nucleic acids and induction of interferons. The cytoplasmic receptors RIG- and 
Mda5 recognize RNA and signals through interaction of their CARD with CARD on the mitochondria-bound 
adaptor protein MAVS. TLR3, TLR7/8 and TLR9 are endosomal receptors which bind dsRNA, ssRNA and 
DNA, respectively. TLR3 uses TRIF as an adaptor, while TLR7/8 and TLR9 are MyD88-dependent. Further 
signaling is cascaded through distinct pathways leading to IRF3 or IRF7 activation and subsequent type I IFN 
induction, alternatively NF-κB activation and induction of inflammatory cytokines. The figure is modified from 
(Kawai and Akira, 2008) and (Kawai and Akira, 2006) by R. Cayers. 
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branches into either an IRF-3 or a NF-κB pathway which both in orchestral cooperation with 
several other transcription factors eventually lead to activation of the IFN-α/β promoter or 
induction of pro-inflammatory cytokines, respectively. Upon detection of dsRNA the TIR 
domain of TLR3 recruits TRIF (TIR-domain-containing adapter-inducing interferon-β) which 
in turn interacts with either TANK-binding kinase 1 (TBK1) leading to IRF3/IRF7 activation 
or receptor-interacting protein-1 (RIP1) leading to activation of a large kinase complex 
consisting of the catalytic subunits IKKα (IκB kinase) and IKKβ plus the NF-κB essential 
modifier (NEMO). The activated IKK complex phosphorylates the inhibitor of NF-κB (IκB) 
and targets this inhibitor for degradation by the ubiquitin-proteasome pathway which 
eventually leads to NF-κB activation (Figure 3). TLR7 is the endosomal receptor of ssRNA, 
predominantly found in plasmacytoid dendrittic cells (pDC). These cells also harbor TLR9, 
the receptor of CpG (unmetylated) DNA, in their endosomes, and are dependent on TLRs for 
IFN induction. The cytoplasmic recognition molecules for  viral RNA, melanoma 
differentiation-associated gene-5 (mda-5) and retinoic acid-inducible gene-I (RIG-I) (Kato et 
al., 2005; Kawai and Akira, 2005) (described below) are not utilized by pDCs. The TLR7 and 
TLR9 mechanism of IFN induction follows pathways that are initially dependent on myeloid 
differentiation factor 88 (MyD88) and interleukin-1 receptor-associated kinases 4 (IRAK4) 
and IRAK1, but otherwise resemble the pathways initiated by TLR3. Host cells also feature 
TLR-independent pathways that lead to IFN production. The intracellular dsRNA sensors, 
mda-5 and RIG-I are widely expressed cytoplasmic RNA helicases which respond to viral 
nucleic acids present in the cytoplasm after viral replication (Andrejeva et al., 2004; Kawai 
and Akira, 2008; Yoneyama et al., 2005). RIG-I contains an RNA helicase domain that binds 
to dsRNA and two amino-terminal caspase activation and recruitment domain (CARD) 
responsible for protein interaction with the CARD of other proteins required for downstream 
signaling events (Seth et al., 2005). RIG-I knockout mice are embryonic lethal, however 
studies using cells derived from these mice show that RIG-I is essential for innate immune 
responses to several RNA viruses in different cell types (Kato et al., 2005). An adaptor 
molecule that connects RIG-I sensing of incoming viral RNA to downstream signaling and 
gene activation has been described by several research groups as a 62 kDa protein and named 
MAVS (mitochondrial antiviral signaling)/IPS-1 (IFN-β promoter stimulator protein 1)/ VISA 
(virus-induced signaling adaptor)/Cardif (CARD adaptor inducing IFN-β) (Hiscott et al., 
2006b), hereafter termed MAVS. This protein is targeted to the mitochondrial membrane by a 
C-terminal transmembrane domain, and has an N-terminal CARD that associates with the 
 - 19 - 
CARD regions of RIG-I and mda-5, ultimately leading to the induction of type I IFNs. 
Silencing of MAVS expression through RNAi abolishes the activation of NF-κB and IRF3 by 
viruses (and poly I:C), thereby permitting viral replication (except in pDC) (Sun et al., 2006). 
Mice lacking MAVS are viable and fertile but are severely compromised in immune defense 
against viral infection. These results provide the in vivo evidence that the cytosolic viral 
signaling pathway through MAVS is specifically required for innate immune responses 
against viral infection (Sun et al., 2006). Some of the details of this pathway have been 
elucidated by showing that whereas RNAi of MAVS blocks IFN-induction by RIG-I, RNAi 
of RIG-I do not inhibit IFN-induction by MAVS, which indicates that MAVS lies 
downstream of RIG-I. Further experiments has shown that MAVS lies upstream of the 
kinases that phosphorylate IRF3 (TBK1) and the NF-κB inhibitor, I B (IKK/NEMO complex) 
(Seth et al., 2005). This is the first example of a mitochondrial protein with a role in innate 
immunity. The fact that MAVS localizes to the mithochondrial membrane suggests a link 
between viral infection, mitochondrial function and development of innate immunity 
(McWhirter et al., 2005).  
JAK/STAT signaling; induction of ISGs 
In mammals, the Janus-activated kinase (JAK)/signal transducer and activator of transcription 
(STAT) pathway is the principal signaling mechanism for a wide array of cytokines and 
growth factors. Such extracellular signaling polypeptides are recognized by specific 
transmembrane receptors or receptor complexes on target cells.  This recognition leads to a 
rapid change in the cellular gene expression critical in many biological processes such as 
developmental regulation, growth control, and homeostasis and anti-inflammatory responses 
in multicellular organisms. Mechanistically, JAK/STAT signaling is relatively simple, with 
only a few principal components (Aaronson and Horvath, 2002). Type I IFNs (IFNα/β) induce 
immune responses through a cell surface, two subunit, transmembrane receptor termed 
IFNAR1/ IFNAR2 (Figure 4). Ligand binding to this receptor results in activation of the 
Janus-activated kinase 1 (JAK1) and tyrosine kinase 2 (TYK2) followed by tyrosine 
phosphorylation of STAT1 and STAT2 (Brierley and Fish, 2002; Garcia-Sastre and Biron, 
2006; Platanias, 2005). A heterodimer of STAT1 and STAT2 associates with IRF9, forming 
the ISGF3 complex which in the nucleus binds to an IFN stimulated response element (ISRE) 
activating the promoters of IFN-stimulated genes (ISGs). Type II IFN (IFNγ) binds to a 
different dimeric receptor, the IFNG1/IFNG2 receptor, and induces receptor tyrosine 
phosphorylation by JAK1 and JAK2 proteins, producing a recruitment site for STAT1 which 
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in turn is phosphorylated. STAT1 
dimerizes and translocates to the 
nucleus to activate transcription 
from GAS (gamma-interferon 
activation site) elements in ISG 
promoters (Aaronson and Horvath, 
2002).  
Figure 4. Type I IFNs bind a common 
receptor composed of the two subunits 
IFNAR1 and IFNAR2 at the cell surface. 
The subunits are associated with TYK2 
and JAK1, respectively. Type II IFNbinds 
another receptor which is also composed 
of two subunits, IFNGR1 and IFNGR2, 
which are associated with JAK1 and JAK2, 
respectively. Activation of type I IFN 
receptor results in tyrosine 
phosphorylation of STAT2 and STAT1 
leading to formation of t STAT1–STAT2–
IRF9, known as the ISGF3 complex. These 
complexes translocate to the nucleus and 
bind ISREs in DNA to initiate gene 
transcription. Both type I and type II IFNs 
also induce the formation of STAT1–
STAT1 homodimers that translocate to the nucleus and bind GAS elements that are present in promoter regions. 
The figure is modified from (Platanias, 2005). 
 
Intercellular signaling is critical for efficient innate immuneresponses, and STAT pathways 
have been found to be evolutionary conserved from slime molds, worms, flies, and vertebrates 
but are absent from fungi and plants (Darnell, 1997). In mammals, there are seven STAT 
proteins that respond to distinct stimuli and induce the transcription of genes that can elicit 
different physiological outcomes; these are, STAT1, STAT2, STAT3, STAT4, STAT5A, 
STAT5B, and STAT6 (Rogatsky and Ivashkiv, 2006). STAT proteins are localized in the 
cytoplasm of unstimulated target cells and remain inactive in the absence of receptor-ligand 
coupling upon which they are rapidly activated through specific binding between STAT Src-
homology 2 (SH2) domains and receptor phosphotyrosine residues. These SH2-
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phosphotyrosine interactions are highly specific and determine the role of the STATs as 
transcription factors. All the STAT proteins contain a defined domain like structure (Figure 5). 
The amino-terminal part of STATs contains a sequence responsible for stabilizing interaction 
between STAT dimers, thereby forming STAT tetramers. The coiled-coil domain facilitates 
interactions to other proteins, and the DNA-binding domain (DBD) forms a nuclear 
localization signal (NLS) upon dimerization. Residues in this domain make direct contact 
with DNA elements in ISG promoters. A nuclear export signal (NES) is also found in this 
domain. The carboxy-terminal part of STATs is composed of a SH2 domain featuring a 
phosphotyrosine binding pocket allowing proteins with phosphorylated tyrosines to bind. 
Next to the SH2 domain is a 
transcriptional activation domain 
(TAD) with a tyrosine 
phosphorylation site critical for 
downstream signaling. A 
conserved phosphoserine site 
within the TAD mediates 
interactions between STATs and 
transcriptional cofactors such as 
histone acetyl transferases (HATs) 
and CBP/p300 (Brierley and Fish, 
2005). 
Figure 5. a. Model of the core structure 
of STAT1 (amino acids 130–712) 
shows binding of a STAT1 dimer to 
DNA. b. The domain-like structure of 




As a consequence of the IFN signaling trough the JAK/STAT pathway an onset of ISGs leads 
to an antiviral state in the host cell. Four main effector pathways of IFN-mediated antiviral 
response has been distinguished: the myxovirus resistance gene (Mx) GTPase pathway, the 
2’,5’-oligoadenylate-synthetase (OAS)- directed ribonuclease L (RNAse L) pathway, the 
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protein kinase R (PKR) pathway and the ISG15 ubiquitin-like pathway (Katze et al., 2002; 
Sadler and Williams, 2008). 
Mx proteins are large (~80 kDa) IFN-inducible GTPases with an enzymatic antiviral activity. 
Mx proteins self-assemble and bind viral nucleocapsids and thereby interfere with 
intracellular trafficking of virus and the activity of viral polymerases, thus inhibiting 
replication of many RNA viruses including influenza (Pavlovic et al., 1990) and measles 
viruses (Schnorr et al., 1993). In humans there are two related Mx proteins (MxA and MxB) 
which of only MxA appears to have antiviral effect (Haller et al., 1998). The two Mx proteins 
identified in mice (Mx1 and Mx2) both confer antiviral activity, although at distinct sub-
cellular locations and with distinct specificity to various viruses (Jin et al., 2001; Staeheli et 
al., 1986). 
OAS is an IFN-induced, dsRNA-dependent enzyme which converts ATP to 2′,5′-linked 
oligoadenylates that activate the latent endoribonuclease RNAse L. By degrading ssRNA the 
RNAse L provides a mechanism of antiviral action, although this pathway also affect cellular 
RNAs implicating an important role in cell growth, differentiation and apoptosis 
(Hovanessian, 2007). 
PKR is a serine/threonine protein kinase which is dimerized and activated by 
autophosphorylation upon binding to dsRNA. PKR exhibits antiviral effect by 
phosphorylating a protein known as eIF-2α, a eukaryotic translation initiation factor. After 
phosphorylation, eIF-2α forms an inactive complex with eIF-2B, thereby leading to reduced 
translation initiation and reduced protein synthesis. This inhibits viral replication and normal 
cell ribosome function, which may lead to killing both the virus and susceptible host cells in 
“self defense” (Garcia et al., 2006). 
One of the most predominantly expressed ISGs is ISG15, a 15 kDa ubiquitin-like protein 
containing two tandem repeats of an ubiquitin-like (UBL) domain. Accordingly, ISG15 can 
conjugate to cellular proteins, but do not target them for proteasomal degradation. The C-
terminal, encoding conserved hydrophobic patches, is sufficient for activation and transfer of 
ISG15 to the IFN-inducible enzymes E1 and E2. However, the N-terminal UBL seems to be 
necessary for E3-mediated conjugation to protein substrates. E1, E2 and E3 proteins 
sequentially catalyse the conjugation of ISG15 to numerous protein substrates to modulate 
multiple cellular responses to inhibit virus production. This process (known as ISGylation) is 
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reversibly regulated by proteases (such as ubiquitin-specific protease 18 (USP18)), which are 
also induced by IFNs (Sadler and Williams, 2008).  
In addition, the IFN-inducible RNA-specific adenosine deaminase ADAR1 can have an 
antiviral effect (George and Samuel, 1999; Patterson et al., 1995). Viral RNAs are subjected 
to A-to-I editing resulting in transcripts that differ from their template. Thus, such RNA 
modification has the potential to alter the protein-coding capacity of the edited transcript. The 
A-to-I transitions also destabilize the dsRNA helix by disrupting base pairing. A cytoplasmic 
endonuclease which specifically cleaves hyper-edited inosine-containing dsRNA (Scadden 
and Smith, 2001), may be an important factor affecting the stability of I-containing RNAs. 
ADAR was first identified as a dsRNA-unwinding enzyme in Xenopus oocytes (Bass and 
Weintraub, 1988). The ~150 kDa human ADAR1 deaminase  was isolated in a screen for 
IFN-regulated cDNAs (Patterson and Samuel, 1995) and has a domain-like structure 
consisting of 3 dsRNA-binding domains, two Z-DNA-binding domains in addition to a 
catalytic domain (Lai et al., 1995; Liu et al., 1997). ADAR1 transcription levels are induced 
by both IFN-α and IFNγ (Patterson et al., 1995). There also exist a smaller (110-kDa), non-
inducible form of ADAR1 which localizes to the nucleus in human cells (Patterson and 
Samuel, 1995). Additionally there is an ADAR2, not inducible by IFN, present in human cells 
(Patterson and Samuel, 1995). A proviral effect of ADAR1 has also been reported (Nie et al., 
2007). Replication of vesicular stomatitis virus (VSV) is enhanced by ADAR1 through a 
mechanism independent of dsRNA editing. The ADAR1 interacts with PKR, inhibits its 
kinase activity thereby suppressing eIF-2α phosphorylation. Consistent with the inhibitory 
effect on PKR activation, ADAR1 increases VSV infection in PKR+/+ mouse embryonic 
fibroblasts; however, no significant effect was found in PKR-/- cells. This proviral effect of 
ADAR1 requires the N-terminal domains but does not require the deaminase domain (Nie et 
al., 2007). 
Finally, many IFN-pathway signaling proteins are themselves ISGs, thus providing a 
feedback loop that amplifies IFN responses; examples are IRF7, RIG-I, Mda-5 and STAT1. 
ISGs are diverse in their biological functions and numerous genes are known to be highly 
induced at transcriptional levels, however many are still poorly characterized functionally. 
With further functional studies, some additional genes of the about 300 genes that are induced 
following treatment with IFN and identified by oligonucleotide microarray studies, could 
prove to be critical mediators of antiviral actions (Maher et al., 2007; Samuel, 2001). 
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Viral “under cover operations” 
In general it seems difficult for a virus to overcome the powerful IFN-induced antiviral 
mechanisms the host cells possess. Anyhow, viral infections and replication occur, enabled 
through a variety of mechanisms that have evolved in viruses to evade host defense. It is 
shown that many viruses dedicate parts of their genome to encode gene products able to 
counteract components of the IFN pathways (Garcia-Sastre and Biron, 2006). The strategies 
could be either to antagonize IFN induction, IFN signaling, expression or action of ISGs 
(Biron, 2001). Influenza A/B (Orthomyxoviridae) NS1 protein (Wang et al., 2000), vaccinia 
virus (Poxviridae) E3L protein (Chang et al., 1992) and the NSP3 protein of rotavirus 
(Reoviridae) (Langland et al., 1994) are examples of well known IFN-antagonists of viral 
origin that all block initiation of IFN production at the transcriptional level. Other viruses 
encode proteins that block IFN signaling. Adenovirus (Adenoviridae) protein E1A decreases 
levels of STAT1 and IRF9 and inhibits the binding of co-activator CBP (CREB binding 
protein) by directly interacting with STAT1 (Leonard and Sen, 1996; Look et al., 1998). 
Simian virus 5 (SV5, Paramyxoviridae) also have a protein (V) that blocks IFN-α/β and IFNγ 
by targeting STAT1 for proteasome-mediated degradation (Didcock et al., 1999). A common 
strategy developed among many viruses is down-regulation of PKR activity to avoid 
jeopardizing their own survival and viral replication. By binding and sequestering dsRNA, 
viral proteins can deprive PKR of its activator and thereby inhibit its kinase activity (Gale and 
Katze, 1998). Poxviruses (Poxviridae) possess multiple strategies of immune evasion; they 
can secrete decoy IFN receptors to prevent initiation of IFN signaling, a viral phosphatase 
dephosphorylates STAT1, and the myxoma virus (MV) is able to block tyrosine 
phosphorylation of TYK2 (Wang et al., 2009). The nonstructural protein NS5A of Hepatitis C 
virus (HCV) is a promiscuous protein with multiple interaction partners among own viral 
proteins and cellular proteins. It shows binding properties to PKR and inhibits binding to, and 
activation by dsRNA. It also leads to up-regulation of pro-inflammatory cytokine interleukin 
8 (IL-8). Both properties result in inhibited IFN activity. Through its interactions NS5A also 
modulates mitogen-activated protein kinase (MAPK) signaling pathways and inhibits antiviral 
actions of IFNs (Macdonald and Harris, 2004). Lower expression levels of  type I IFN, 
STAT1 and IRF9, in addition to reduced DNA-binding activity of the STAT/IRF9 complex to 
the ISG promoter upon HCV infection, indicate additional inhibition of the JAK/STAT 
signaling pathway (Blindenbacher et al., 2003). This impairment of JAK/STAT signaling is 
probably caused by inhibition of the extracellular signal-regulated kinase (ERK) MAPK 
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through an interaction between NS5A and the adaptor protein Grb2 (Tan et al., 1999). 
Furthermore, the HCV NS3/4A protease specifically cleaves MAVS as part of its immune-
evasion strategy (Hiscott et al., 2006a). These studies highlight the diversity of survival 
strategies among viruses. 
What about fish? 
Fish are now known to possess many of the ligands, receptors, and signaling adaptor 
molecules necessary for antiviral responses, and knowledge about the fish immune system is 
emerging, although some key molecules known in mammalian systems are still not identified 
or characterized in fish. 
Virus recognition / IFN­initiation in fish 
Signaling pathways for induction of IFN in teleost fish are likely to be similar to mammalian 
pathways as fish homologs of receptors and downstream signaling factors have been 
identified (Purcell et al., 2006; Stein et al., 2007). Receptors for viral nuclear acids such as 
RIG-I and mda-5 (recognition of dsRNA) are strongly expressed in salmon head kidney 
leukocytes, whereas TLR7/8 (recognition of ssRNA) and TLR3 (recognition of dsRNA) are 
expressed at much lower levels (Sun et al., 2009), indicating that RIG-I and mda-5 might be 
the major viral sensors in salmon. Recently RIG-I along with MAVS was cloned from several 
fish species including Atlantic salmon (Biacchesi et al., 2009). Additionally, sequences 
related to MAVS has been identified even in the lowest vertebrates, chondrichthyes 
(cartilaginous fish) and agnatha (jawless vertebrates) indicating the importance of this 
molecule in evolution. Like the mammalian MAVS, salmon MAVS is a transmembrane 
protein located at the mitochondria. Overexpression of MAVS induces antiviral immunity 
against several viruses (VHSV, IHNV and SVCV) and is dependent on the CARD and 
transmembrane domains (Biacchesi et al., 2009). The spleen is shown to be the salmon organ 
expressing the highest levels of TLR8, but TLR8 is also present at low levels in head kidney, 
kidney and gills (Skjæveland et al., 2009). Pufferfish and zebrafish have a broader distribution 
of TLR8 in their organs, whereas low TLR8 expression is found in the spleen from these 
species (Jault et al., 2004; Oshiumi et al., 2003). In the Atlantic salmon cell-line TO TLR7/8 
is weakly expressed, but is inducible by both type I and type II IFN (Skjæveland et al., 2009; 
Sun et al., 2009). Distinct recognition patterns may apply in different cell types. TLR3 is 
cloned from rainbow trout and displays a genomic organization similar to mammalian and 
other fish TLR3 genes. It responds with increased levels of gene expression upon stimulation 
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with poly I:C and challenge with IHNV (Rodriguez et al., 2005). The discovery of a dsRNA 
receptor, named TLR22, shows that fish have a dual dsRNA recognition system. TLR22 is is 
unique for lower vertebrates and is localized to the cellular membrane, recognizing 
extracellular nucleic acids (Matsuo et al., 2008).  Despite extensive searching (Roach et al., 
2005) this subfamily of TLRs have not so far been identified in mammals.  
IFN genes in fish 
Currently, only type I and II IFNs have been identified in fish. The two types of IFN are not 
structurally related, and are classified on basis of their receptor recognition and mechanisms 
of gene activation. All fish IFN genes identified contain four introns (except Japanese medaka 
IFN with three introns), a gene structure resembling mammalian IFNλ (type III IFN), while 
their protein sequences are more similar to mammalian IFNα/β. Hence, a certain disagreement 
on how to classify the teleost IFNs has become evident as the high degree of sequence 
divergence from mammalian IFN has made grouping equivocal (Levraud et al., 2007; 
Robertsen, 2006; Sun et al., 2009).  
IFNs, which functionally correspond to mammalian type I IFNs, have been cloned from a 
number of fish species, including Atlantic salmon, rainbow trout, channel catfish, pufferfish, 
stickleback, zebrafish, Japanese medaka and recently, sea bass  (Casani et al., 2009; NCBI, 
2009; Robertsen, 2006). Lately fish type I IFNs have been further classified into two groups 
based on their primary protein sequences. In rainbow trout three type I IFNs have been 
isolated. Like most mammalian type I IFNs (except β and ε), recombinant rtIFN1 and rtIFN2 
both contain two cystein residues. They both up-regulate expression of Mx and inhibit VHSV 
replication in RTG-2 cells. These are placed in group I.  In contrast, recombinant rtIFN3 
belonging to group II was found to be a poor inducer of Mx and antiviral activity. The three 
rtIFNs also showed differential expression in cells and tissues (Zou et al., 2007), suggesting 
distinct functions of the three subtypes in the immune system of fish. A similar sequence-
based grouping has been designated in zebrafish. Whereas group I contains one gene with a 
powerful, but slow rate, antiviral and pro-inflammatory induction, group II consists of two 
genes unable to induce inflammatory response, but rather induce a rapid and transient 
expression of antiviral genes. Thus, these two groups of IFN genes have complementing roles 
(Lopez-Munoz et al., 2009). Several type I IFNs have been characterized in Atlantic salmon 
(Robertsen et al., 2003; Sun et al., 2009). Elleven genes encode IFNs that can be categorized 
into three subtypes; IFNa (two genes, IFNa1/IFNa2), IFNb (four genes) and IFNc (five genes). 
IFNa posses an NF-κB site in their promoters and are strongly up-regulated by poly I:C, 
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suggesting that salmon IFNa1/IFNa2 are induced through similar pathways as human IFN-β. 
IFNb genes are suggested to be induced through a pathway similar to mammalian IFN-α, 
whereas IFNc genes showed expression patterns different from both IFNa and IFNb (Sun et 
al., 2009).  
IFNγ, mainly produced by CD4+ T helper 1 (Th1) lymphocytes and NK cells in response to 
MHC-presented antigens, is regarded as one of the hallmarks of the Th1 immune response in 
birds and mammals. Whether lower vertebrates such as fish have developed the equivalent of 
a Th1 immune system has been questionable until the IFNγ gene was identified in rainbow 
trout (Zou et al., 2005), two species of puffer fish (Igawa et al., 2006; Zou et al., 2004), 
zebrafish (Igawa et al., 2006), channel catfish (Milev-Milovanovic et al., 2006) and in 
goldfish (Grayfer and Belosevic, 2009). Some of its biological activities was characterized in 
fish for the first time by Zou et al. (2005) who demonstrated that trout IFNγ was functionally 
similar to its mammalian counterpart, and that at least some of the intracellular signaling 
pathways are conserved. In addition fish IFNγ has proven to induce antiviral ISGs such as Mx 
(Jørgensen et al., 2007; Martin et al., 2007b) and also TLR8 and TLR9 in salmon (Skjæveland 
et al., 2009; Skjæveland et al., 2008). Several fish species have two evolutionary conserved 
IFN-gamma genes possibly as a consequence of a duplication event in teleosts after the 
tetrapod-fish split (Savan et al., 2009). The presence of key elements like types I and II IFN 
and NK cells witness of a fish immune system not unlike the one found in mammalian. 
Revealing whether salmonids and other fish species possess specialized high IFN producing 
cells such as pDCs or if these cells appeared later in evolution will shed new light on the 
evolutionary process of the immune system. 
IFN receptors in fish 
A two subunit receptor (zCRFB1 and zCRFB5) of the class II helical receptor family has been 
identified for zebrafish virus-induced IFN (zIFN) (Levraud et al., 2007). The authors of this 
paper have classified the virus-induced IFN and its receptor as type III IFN, based on the 
organization of the zIFN gene (four introns) and the protein structure of the identified receptor 
components. These authors have previously also described this family of receptors (CRFB 1-9) 
in Tetraodon nigroviridis (green spotted puffer) (Levraud et al., 2007; Lutfalla et al., 2003). 
Other authors claim that these IFNs characterized in zebrafish and pufferfish resembles the 
type I IFNs characterized from other fish species and hence these receptors must be appointed 
type I IFN receptors (Børre Robertsen, personal communication). Recently, two putative 
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transmembrane receptor chains for fish IFNγ were cloned from rainbow trout (Gao et al., 
2009). Characterization by conserved domain analyses, phylogeny, expression analyses and 
ligand binding analyses all suggest that these novel molecules resemble the mammalian IFNγ 
receptors. 
IFN signaling in fish 
Although little is known about the factors that contribute to IFN signaling in fish, some 
proteins involved in the signaling pathway have been cloned. TYK2 and JAK1 have been 
cloned from pufferfish (Tetraodon fluviatilis) (Leu et al., 1998; Leu et al., 2000), and STAT1 
has been cloned from zebrafish (Oates et al., 1999), crucian carp (Zhang and Gui, 2004), 
rainbow trout (GeneBank accession nos: U60331, U60332) and Atlantic salmon (own 
unpublished data; (Collet et al., 2008)). Functional analyses of zebrafish STAT1 protein 
shows that it rescues interferon-signaling in a STAT1-deficient human cell line (Oates et al., 
1999) This indicates that cytokine signaling mechanisms are likely to be conserved between 
fish and tetrapods. Recently also a STAT2 protein was identified in Atlantic salmon (Collet et 
al., 2009). 
Fish Mx promoter 
The rainbow trout Mx1 promoter has been cloned and characterized and was shown to contain 
a TATA box at −29 to −25, a 13 nucleotide ISRE between −101 and −89, and a Sp1 binding 
site at −382 to −374. The ISRE element with the sequence TGAAAGTGAAACA had high 
homology to ISRE elements found in mammalian IFN-induced genes (Collet and Secombes, 
2001). The rainbow trout Mx promoter has also been shown to respond to poly I:C (Collet 
and Secombes, 2001) as well as both salmon IFN-α/β and trout IFNγ in a dose-dependent 
manner, while there was no response to TNF-α and IL-1β  (Johansen et al., 2004). A construct 
featuring the Mx promoter in front of a luciferase reporter gene has been a useful tool for 
studying regulation and induction of IFN responses in teleost fish (Johansen et al., 2004). A 
salmon cell line with this construct integrated in the genome has been established as an even 
more utile tool for these studies (Jørgensen et al 2007). Also Japanese flounder Mx is cloned 
and similar to rainbow trout its promoter contains a TATA box (-24 to -30, whereas it has two 
ISREs (-69 to -80 and -508 to -521) and two Sp1 sites (-563 to -572 and -994 to -1003) (Ooi 
et al., 2006). Mx expression is increased more than 10-fold after stimulation by poly I:C. 
Deletion mutational analyses has revealed that the ISRE closest to the transcription start site is 
crucial for promoter activity. The distal ISRE is not able to induce promoter activity by itself, 
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but contributes to maximal activity in co-presence with the proximal ISRE. Both ISREs bind 
transcription factors. Induction of luciferase by poly I:C is inhibited by a PKR inhibitor, in a 
dose-dependent manner, suggesting that PKR may be required as a signal transducer for type 
I IFN signaling in fish (Ooi et al., 2006). 
Fish ISGs 
Until recently, few ISGs had been identified in fish. A study using Atlantic salmon cDNA 
microarray showed up-regulation of 47 genes in an Atlantic salmon cell line (SHK-1) 
stimulated by recombinant trout IFN1 and by type II IFN, 72  partially overlapping genes 
were upregulated (Martin et al., 2007b). Mx is still the best characterized among them. The 
Mx gene has been cloned from many different species including Atlantic salmon, rainbow 
trout, Atlantic halibut, Japanese flounder, channel catfish, gilthead sea bream and zebrafish. 
Expression studies of Mx has shown that transcription and protein synthesis is inducible by 
IFN, poly I:C and viral infections (Robertsen, 2006). The protein is expressed in the nucleus 
as well as in the cytoplasm and has been proven to have antiviral effect against IPNV in 
salmon (Larsen et al., 2004), the IPNV related sole aquabirnavirus in Senegalese sole 
(Fernandez-Trujillo et al., 2008), IHNV in brown trout (Saint-Jean and Pérez-Prieto, 2007), a 
nodavirus in grouper (Lin et al., 2006) and two rhabdoviruses in Japanese flounder (Caipang 
et al., 2003). The ubiquitin-like protein ISG15 is also identified in fish species like Atlantic 
salmon (Røkenes et al., 2007), Atlantic cod (Seppola et al., 2007), crucian carp (Zhang et al., 
2007) and black rockfish (Baeck et al., 2008). Like Mx, this gene is highly induced by IFN, 
poly I:C and viral infection. Among the less chatacterized proteins are 10 virus-induced genes 
(vigs) identified in rainbow trout which are also found to be induced by IFN-like activity in 
trout leukocytes (Babiuk et al., 2000; Boudinot et al., 1999; Boudinot et al., 2001; O'Farrell et 
al., 2002). vig-3 has a sequence very similar to Atlantic salmon ISG15. vig-4 is homologous 
to the ISG56/ISG58 family of mammalian proteins, which are proteins that interfere with 
protein synthesis. vig-7 and vig-8 are homologous to CXC chemokines. The chemokine 
CXCL10 and two proteins of unknown function, ISG12 and GIG2, have been identified as 
IFN-induced proteins in Atlantic salmon (Martin et al., 2007a; Robertsen, 2008). PKR-like 
eIF2α kinases called PKZ due to their Z-DNA-binding capacity have been discovered in fish. 
PKZ is structurally similar to mammalian PKR with 11 conserved kinase subdomains in the 
C-terminal catalytic domain whereas the N-terminal domain contains two Z-DNA-binding 
domains instead of the two dsRNA binding motifs seen in PKR (Bergan et al., 2008; Hu et al., 
2004; Rothenburg et al., 2005). PKZ is up-regulated by viral infection and has a possible 
 - 30 - 
capability of preventing protein synthesis, although the ability to inhibit virus replication is 
unknown (Rothenburg et al., 2005; Zhu et al., 2008). Additionally, a cDNA encoding PKR 
protein has recently been isolated from Japanese flounder and found to interact with, and be 
responsible for phosphorylation of eIF2α and thereby confer antiviral activity against 
Scophthalmus maximus rhabdovirus (SMRV) (Zhu et al., 2008). Also fish homologs of the A-
to-I RNA editase ADAR have been identified in two species of pufferfish in addition to 
zebrafish (Slavov et al., 2000). The gene structure and organization are highly conserved; 
although the different RNA-binding domains (RBD1/2/3) have different levels of 
conservation, which probably reflect the differences in editase substrate specificity and/or 
substrate sequence conservation (Slavov et al., 2000). Although nine IRF members are found 
in mammals only fish homologues of IRF1, IRF2, IRF3 and IRF7 have been identified. These 
are all trancriptionally up-regulated by viruses and dsRNA (poly I:C) (Caipang et al., 2005; 
Collet and Secombes, 2002; Holland et al., 2008; Ooi et al., 2006). Rainbow trout IRF3 genes 
are transcriptionally modulated by the same range of ligands as IRF7, which is distinct from 
mammals, where IRF3 transcription is not influenced by viral infection nor IFN treatment 
(Holland et al., 2008). Only IRF1 has been functionally assessed in fish through the 
examination of nuclear translocation events and the ability of over-expressed IRF1 to induce 
an antiviral state in carp EPC cells (Caipang et al., 2005; Ooi et al., 2006). 
IFN antagonism in fish 
The recent literature is rich with descriptions of viral interference with antiviral signaling in 
mammals (Haller et al., 2006; Randall and Goodbourn, 2008; Unterholzner and Bowie, 2008), 
still little is known about the ability of fish viruses to antagonize the host immune responses. 
One recent example, though, is the infectious salmon anemia virus (ISAV), which is closely 
related to influenza A. An ORF on segment 7 of ISAV encodes a protein (s7ORF1) which has 
shown abilities to down-regulate the action of IFN rather than the production (McBeath et al., 
2006). However, this is contradicted by García-Rosado et al. (2008), where the s7ORF1 
protein and a protein encoded by segment 8 (s8ORF2) both are, independent of each other, 
shown to inhibit the type I IFN promoter activation. Another example of immune evasion is 
from betanodavirus, a bipartite, positive-sense RNA virus, which is the causative agent of 
viral nervous necrosis in marine fish. The B2 protein encoded by this virus is a sequence-
independent dsRNA binding protein. By coating the viral dsRNA it prevents Dicer enzyme 
from generating small interfering RNA (siRNA). dsRNA-sequestration also enables this 
protein to interact with the dsRNA binding domain of ADAR1 and thereby block RNA 
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editing. Despite this activity, B2 is unable to block the induction of the dsRNA-dependent 
IFN response (Fenner et al., 2006). There are also indications that IPNV possess strategies to 
circumvent host immunity. Infection with IPNV in RTG-P1 cells stimulated with IFN is 
found to significantly suppress Mx transcription compared to uninfected, IFN-stimulated cells 
(Collet et al., 2007).  
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Aims of study 
Major loss in farming of Atlantic salmon is caused by IPNV. The existing vaccines do not 
give satisfactory protection. In order to optimize efficacy of vaccines, the mechanisms 
mediating protection against IPNV in salmonids need to be elucidated. Knowledge about 
IPNV interactions with the host’s antiviral immune defence can contribute to development of 
efficient prophylactic strategies. The aims of this project were to: 
• Apply new molecular techniques such as the yeast two-hybrid system and co-
immunoprecipitation to study protein-protein interactions among IPN viral proteins.  
• Study protein-protein interactions between IPN viral proteins and host proteins. 
• Study the protective ability of recombinant IFN-α1 against IPNV infection. 
• Study the IFN-antagonistic properties of IPNV and elucidate candidate molecules 
responsible for these properties. 
• Functional studies of novel Atlantic salmon molecules involved in the JAK/STAT 
signaling pathway. 
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Summary of papers 
Paper 1. VP3, a structural protein of the infectious pancreatic necrosis 
virus, interacts with the RNA-dependent RNA polymerase VP1 and with 
double-stranded RNA.  
Torunn Pedersen, Astrid Skjesol and Jorunn B. Jørgensen  
In paper 1 we focus on the interaction properties of VP3, the suggested key organizer of 
particle assembly in birnaviruses. By applying the yeast two-hybrid system in combination 
with co-immunoprecipitation, VP3 was proven to bind to VP1 and to self-associate strongly. 
In addition, VP3 was shown to specifically bind to dsRNA in a sequence independent manner 
by in vitro pull-down experiments. The binding between VP3 and VP1 was not dependent on 
the presence of dsRNA. Deletion analyses mapped the VP3 self-interaction domain within the 
101 N-terminal amino acids and the VP1-interaction domain within the 62 C-terminal amino 
acids of VP3. The C-terminal end was also crucial, but not sufficient for the dsRNA binding 
capacity of VP3. For VP1, the 90 C-terminal amino acids was the only dispensable part for 
maintaining the VP3-binding ability. Kinetic analysis revealed the presence of VP1-VP3 
complexes prior to the formation of mature virions in IPNV-infected CHSE-214 cells, which 
indicates a role in promoting the assembly process.   
 
Paper 2. The interplay between infectious pancreatic necrosis virus (IPNV) 
and the IFN system: IFN signaling is inhibited by IPNV infection 
Astrid Skjesol, Toril Aamo, Marit Nøst Hegseth, Børre Robertsen and Jorunn B. Jørgensen 
Indications of IPNV being able to evade or counteract innate host defense come from its lack 
of ability to induce strong type I interferon (IFN) responses in cell culture. We show in paper 
2 that administration of salmon rIFN-α1 to cells prior to IPNV infection halts the viral protein 
synthesis and prevents processing of pVP2 into mature VP2. Furthermore, compared to 
pretreatment with IFN-α1 the antiviral state in cells infected with IPNV prior to IFN treatment, 
was antagonized by IPNV. This was shown by higher viral titers, faster viral protein synthesis 
and also by reduced Mx expression. The longer headstart the virus gets, the more prominent is 
the weakening of IFN signaling. IPNV VP4 and VP5 inhibit IFN-induced expression from the 
Mx promoter, indicating that these proteins contribute to the antagonistic effect.  
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Paper 3. Structural and functional studies of the STAT1 gene from Atlantic 
salmon 
Astrid Skjesol, Tom Hansen, Cheng-Yin Shi, Hanna Leena Thim and Jorunn B. Jørgensen  
In paper 3 we identified a salmon STAT1 homologue with a domain-like structure and 
functional motifs similar to STAT1 in higher vertebrates. These include an amino-terminus 
that stabilizes interaction between STAT dimers in a promoter-binding situation, a coiled coil 
domain facilitating interactions to other proteins, a central DNA-binding domain, a SH2 
domain responsible for dimerization of phosphorylated STATs and conserved 
phosphorylation sites within the carboxy terminus. The latter is also the transcriptional 
activation domain. The salmon STAT1 was shown to be ubiquitously expressed in the 
cytoplasm of various cells. It was tyrosine phosphorylated in response to recombinant type I 
and type II IFNs both in primary leukocytes and in a salmon cell-line. Treatment with (type II) 
IFN also led to nuclear translocation of STAT1 within one hour. The ability of salmon 
STAT1 to dimerize was also shown in this paper. 
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General discussion 
One of the most important functions of the IFN system is to inhibit viral infections. The 
delicate balance between the antiviral mechanisms of the host cells and the viruses’ 
counteracting mechanisms has been the subject for this study. Characterization of interactions 
between IPNV proteins was our first approach to better understand this interplay from the 
viral perspective (paper 1). We discovered that the structural protein VP3 was able to bind to 
dsRNA offering a possible explanation for the inability of IPNV to induce IFN and ISGs in 
certain cell-lines. If the viral dsRNA is being chaperoned or masked by VP3, and thereby 
stays hidden from the cell’s dsRNA sensors, the antiviral induction might be avoided. Such a 
role for VP3 has yet to be proven. IPNV seemingly exerts several approaches to convey the 
IFN system, as this virus is able to counteract type I IFN even when IFN is supplemented to 
cells during viral infection. Although, administering of IFN to cells 24 h prior to IPNV 
infection settles a strong antiviral state which the virus is unable to overcome. In this situation, 
the induction and Mx-expression is high, the viral titers low, and interestingly, the processing 
of VP2 is delayed or inhibited. When the virus gets a headstart on IFN signaling though, 
induction of Mx is lowered, viral titers increased and VP2 processing sustained. Analysis of 
the individual IPNV protein’s ability to antagonize induction of the Mx-promoter when 
stimulated with IFN revealed that VP4 and VP5 were the two most presumtive candidates 
causing this effect (paper 2). The JAK/STAT signaling pathway is the signature IFN signaling 
pathway downstream of IFN production. The presumed targets for the antagonistic effect 
possessed by VP4 and VP5 is most likely molecules along this route. In fish, many of the 
players involved in signaling downstream of IFN is not yet characterized. In this work, we 
have characterized a major player in this pathway; STAT1. By utilizing a STAT1 specific 
antibody we showed that salmon STAT1 was tyrosine phosphorylated and translocated into 
the nucleus (within 1 h) upon IFN stimulation in certain salmon cell types (paper 3). The 
expression level of STAT1 mRNA in various tissues was examined in addition to STAT1 
mRNA and protein expression upon IFN and viral stimuli in various cell types. The STAT1 
reported by us was slightly different from two other salmon STAT1s recorded in GenBank, 
although they all shared the domain-like structure typical of the STAT proteins. Despite the 
evolutionary conservation and apparent similar functionality of the IFN system among the 
vertebrates, differences occur, and further characterization is needed in fish to fully 
understand the interplay between pathogens and host cells. One interesting differences 
between mammals and piscine species is the existence of a surface RNA recognition system, 
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namely TLR22. Pufferfish TLR22 expression responds to double-strand RNA similarly to 
how TLR3 responds in humans (Matsuo et al., 2008). This respons is also similar to the TLR3 
response in fish. The question is why teleosts have doubled their inventory of dsRNA 
recognition receptors. 
The results are discussed in detail in the respective papers. In the following sections some 
selected topics, updates and general aspects of this work will be addressed. 
The significance of the protein-protein interactions in IPNV 
New approaches and techniques within the field of fish immunology, such as the yeast two-
hybrid (Y2H) system combined with co-immunoprecipitations have provided extended 
knowledge about each individual protein that constitutes the IPN virion and how they interact 
with each other. This might contribute to our understanding of the role each protein has in the 
replicative cycle of the virus and defining specific factors required for infectious virus 
production and persistence. Our studies (in paper 1) revealed that VP3 interacts with itself 
through an N-terminal domain. The self-interaction enables the scaffolding of the capsomer, 
even without a detectable direct interaction with the outer capsid protein VP2. Through its C-
terminal VP3 interacts with the RdRp VP1. This interaction is dependent on a full-length VP1 
protein, and the interaction domain on VP3 has recently, by a peptide-array been more closely 
mapped to the 10 C-terminal amino acids (results not shown). This complex formation is 
RNA-independent and takes place before viral particles appear. Thus it seems to play a role in 
viral assembly. Additionally, VP3 binds to dsRNA in a sequence-independent manner in the 
absence of other factors and confers a status as a multipotent protein within the virion. This 
was detected applaying an in vitro translation and dsRNA-binding assay. As expected, we 
also found that the outer capsid protein VP2 was able to self-interact (results not shown). To 
further evaluate the function of each IPNV protein and the significance of their interactions, 
reverse genetics would be a valuable and necessary tool. By reverse genetics also the 
importance of molecular differences between isolates with high and low virulence can be 
elucidated. This technique has been applied for IPNV and other birnaviruses by other research 
groups (Da Costa et al., 2002; Yao and Vakharia, 1998), although attempts to establish this 
technique for IPNV have not so far been successful in our lab. Resolving the structure of 
proteins by X-ray crystallography might also reveal useful information about the individual 
IPNV proteins and their putative functions. New crystallography research on IBDV has 
revealed that the interaction of the VP3 C-terminal with VP1 promotes conformational change, 
making the polymerase active site available (Garriga et al., 2007). Thus, VP3 acts as a 
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transcriptional activator consistent with the structural features revealed by crystallization of 
the central region of VP3 (Casañas et al., 2008). The structure of the VP4 Ser/Lys proteases 
from IPNV along with other birnaviruses, such as the blotched snakehead viris (BSNV) 
(Feldman et al., 2006) have been revealed. This has provided insights into the catalytic 
mechanism and substrate recognition of these types of proteases, making VP4 protease a 
potential target for antiviral therapy. Although IPNV and BSNV VP4 share only about 19% 
sequence identity, their overall structure and probably also their function is much conserved. 
The role of IPNV proteins interactions with host cells  
Probably the most important, but also the most challenging problem in IPNV biology is to 
define the specific factors in the host environment that is affected by IPNV infection. There 
are several possible approaches to target these factors. The yeast two-hybrid system is a tool 
which can bee applied in screening for host molecules interacting with viral proteins, using a 
whole library approach. Other methods such as co-IP using virus protein antibodies and 
subsequent identification of interacting proteins by protein sequencing (MALDI/TOF MS) 
can be utilized. A virus overlay protein binding assay (VOPBA) has been applied by 
Ørpetveit et al. (2008) in their search for host proteins binding to IPNV proteins. From a 
membrane fraction of cellular proteins, a band of high molecular weight (~220 kDa), but with 
unidentified sequence, was shown to interact with IPNV. This protein was detected by a VP3 
antibody (in addition to anti-IPNV) which is surprising since VP3 is thought to be a protein 
contained within the particle. This is however debatable, as some authors claim that a portion 
of VP3 is displayed on the virion surface (Caswell-Reno et al., 1986; Tarrab et al., 1993). 
Similarly a 250 kDa unidentified cellular protein from three fish cell-lines has been proposed 
to be the virus receptor for the closely related marine aquabirnaviris (MABV) based on 
interaction in a VOPBA (Imajoh et al., 2003). We show in paper 2 that processing of the 
premature pVP2 into the mature VP2 is stalled in the prescence of IFN prior to infection. In 
IBDV, processing of pVP2 (residues 1 to 512) is studied further by a reverse genetics system. 
Processing of pVP2 generated VP2 and four small peptides (6, 6, 10 and 45 amino acids in 
length, respectively). At least three of these peptides are associated with the viral particles. 
Mutants lacking the two smallest peptides are viable, although the virus growth is affected. In 
contrast, deletions of either of the two largest peptides do not allow virus recovery. 
Substitution analyzes pinpoints the essential residues to be mainly at the cleavage sites (Da 
Costa et al., 2002) . 
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Immune-regulatory responses to IPNV 
Viral infection certainly triggers induction of IFNs and ISGs in vertebrates due to the large 
number of immune cells and the many viral sensors in host cells. IPNV induces both IFN and 
Mx in Atlantic salmon in vivo (McBeath et al., 2007). However, induction is cell-type specific, 
as IPNV induces neither IFN nor Mx or ISG15 during infection of TO cells or CHSE-214 
cells (Jensen and Robertsen, 2002; Røkenes et al., 2007), while IFN-transcripts are induced in 
Atlantic salmon macrophages and RTG-2 cells upon IPNV infection (Collet et al., 2007). 
Additionally, IFN-stimulated genes such as IRF1 and IRF2 are up-regulated during IPNV 
infection in RTG-2 cells (Collet et al., 2007). Ingerslev et al. (2009) have shown that in 
addition to type I and II IFN and Mx, IL-10 is highly induced in Atlantic salmon lymphoid 
organs after challenge with IPNV. In mammals, IL-10 is known as a Th2 cytokine, which 
inhibits synthesis of cytokines in an immunosuppressive manner. However, piscine IL-10 is 
suggested to function as an inflammatory cytokine. IL-10 is also known as an inhibitor of 
IFNγ in mouse (Inoue et al., 2005). Another marker for innate immune response, the 
proinflammatory cytokine IL-1β is weakly induced by IPNV infection. The T-cell receptor-α 
(TCR-α), its associated molecule CD8-α and the major histocompatibility complex class-I and 
II molecules (MHC-I and II) are markers of T-cell immunity and all of these except MHCII, 
are moderately induced by IPNV. Also a marker for humoral immunity, the gene coding for 
membrane bound immunoglobulin isotype M (mIgM) is moderately upregulated (Ingerslev et 
al., 2009). IPNV infection induces salmon Annexin 1, an anti-apoptotic gene (Hwang et al., 
2007), possibly a viral strategy to promote successful replication. Knocking down Annexin 1 
expression by siRNA is not of significance for the expression levels of IPNV proteins at early 
stages of infection (until 10 h p.i.) although titers are reduced by 75% and apoptosis increased. 
No direct interaction between Annexin 1 and viral proteins is reported. Preliminary results 
from a microarray showing gene expression in head kidney from fish challenged with a 
virulent field isolate of IPNV and a nonvirulent field isolate compared to uninfected fish 
shows slight up-regulation  of several genes (between 1.1 and 2.3 fold) in the most virulent 
strain at 13 days p.i. (own unpublished results). Only few of these up-regulated genes are 
known to be involved in IFN signaling, supporting our previous results showing that IPNV 
does not induce IFN efficiently and/or IFN signaling is inhibited. A closer examination of 
gene expression (by qPCR) of some genes of interest from the same material, showed a 8-fold 
induction of STAT1 and a 3 fold up-regulation of TLR8 with the most virulent strain, whereas 
the TLR22 was not induced (own unpublished results). 
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Vaccine development 
Some effort has recently been made to improve the efficacy of vaccines against IPNV. New 
reports show that alternative ways of expressing the viral capsid protein VP2 give distict 
antibody responses. Small (~20 nm) subviral particles composed solely of VP2 are formed by 
expression of the VP2 gene in yeast. These particles induce anti-IPNV antibodies in rainbow 
trout vaccinated either by injection of purified VP2-subviral particles or by feeding 
recombinant yeast expressing VP2. A challenge study of vaccinated trout with a heterologous 
IPNV strain shows that both injection and orally vaccinated fish have lower IPNV loads than 
the non-vaccinated fish (Allnutt et al., 2007). In a different study, VP2 isolated and purified 
from IPNV virions gives a more responsive antibody when injected in rabbits than a 
recombinant VP2 expressed from E.coli. Both antisera react equally well with authentic and 
recombinant VP2 in Western blots and ELISAs. However, only the antibodies made against 
authentic VP2 neutralize IPNV infection in CHSE-214 cells and aggregate virions, indicating 
that a posttranslational modification of the virus protein such as carboxylation is required 
(Fridholm et al., 2007). Initial steps have recently been taken in the development of DNA-
vaccines against IPNV. Experimental vaccination of Atlantic salmon with a plasmid that 
express the entire large ORF of  IPNV Segment A  gives a high level of protection, whereas 
other plasmids expressing only VP2 give low protection and plasmids expressing only parts 
of VP2 or VP3 are not protective (Mikalsen et al., 2004). This might indicate that 
posttranslational proteolytic processing of the polyprotein is important for inducing 
immunogenic protection. Another study shows that in addition to the production of specific 
antibodies at 30 days post vaccination, also early immune responses are induced by 
expression of the IPNV VP2 in brown trout. In vitro (BF-2 cells) VP2 expression induces an 
antiviral state protective against homlogous (IPNV) and heterologous (IHNV) viruses. In 
DNA-vaccines adjuvant factors may be present in the expression vector in the form of CpG 
motifs which can contribute to immunostimulatory responses. These results suggest that the 
VP2 gene is a potential candidate for the design of DNA-vaccines, although adjuvant factors 
and the acquisition of posttranslational modifications must be considered (de las Heras et al., 
In press).  
The antagonistic effect of IPNV 
Most viruses have evolved strategies to evade host immune responses in order to promote 
own existence. IPNV is a sucessful pathogen with a wide specter of susceptible hosts, 
indicating that the virus has the potential to escape diverse immune mechanisms. The inability 
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of IPNV to induce IFN synthesis and thereby ISGs such as Mx in certain cell types support 
our proposed theory that the virus possess a mechanism to circumvent the initial offset of 
danger-signaling in the host cell. Whether the binding of VP3 to the genomic dsRNA is a 
mechanism for IPNV to avoid IFN induction has yet to be proven. The IPN virus is also able 
to down-regulate the induction of ISGs which is activated by exogenously administered IFN 
(paper 2), suggesting yet another mechanism involved in signaling pathway downstream of 
IFN induction. We have suggested VP4 and VP5 to be candidate molecules participating in 
this action, although we have not been able to pinpoint the exact stage this occurs and which 
host molecules they target. More factors involved in IFN signaling need to be characterized in 
fish, and their expression and mode of action need to be clarified in the different cell-lines we 
utilize as tools. Several viruses target STAT or JAK proteins for degradation (Didcock et al., 
1999; Parisien et al., 2001; Parisien et al., 2002) or otherwise inhibit their activation (Polyak 
et al., 2001). Neither of the five virally encoded proteins VP1-VP5 of IPNV were able to 
interact directly with ssSTAT1a in a Y2H assay (results not shown), predicting that the target 
for the antagonistic effect of this virus is either an intermediate binding partner to STAT1 or 
another player in the IFN signaling pathway. Interestingly, we have preliminary data showing 
that IPNV has the ability to impair IFN-a1 (formerly named IFN-α1) induced phosphorylation 
of STAT1, whereas IFNγ-induced phosphorylation of STAT1 is not affected (own 
unpublished results). The effect of each individual viral protein in this inhibition of STAT1 
activation/phosphorylation is currently being examined. Screening an Y2H library with the 
different IPNV proteins as bait might identify other host molecules as putative targets for the 
antagonistic effect of the virus. Additionally, the interacting ability of activated STAT1 needs 
to be elucidated.  
The role of STAT1 
The ssSTAT1a was initially cloned and used in a two-hybrid matrix in a direct approach to 
identify protein partners interacting with IPNV proteins. No positive interaction was 
identified, although the characterization of STAT1 as a key molecule in the JAK/STAT 
pathway was pursued further (paper 3). During this work two other salmon STAT1 genes 
were published (Collet et al., 2008) or submitted to GenBank (accession no. BT045567). The 
existence of more than one isotype of STAT1, with distinct transcriptional activation domains 
could indicate selective transcriptional activation upon stimulation.  
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Expression levels of STAT 
The levels of STAT1 mRNA is previously shown to increase slightly 2 – 4 days after IPNV 
infection, and as late as 5 – 6 days after ISAV infection. The latter with a more potent 
induction than IPNV (Collet et al., 2008). In vitro studies of ISAV infected TO cells shows 
increased STAT1 transcription, although at much earlier timepoints (24 – 84 h p.i.) than 
detected by in vivo infection  (Kileng et al., 2009). The same authors show that Poly I:C, like 
IPNV, is a weak inducer of STAT1. Contradicting results are reported by Collet et al. (2007) 
where STAT1 in RTG-P1 cells seem to be highly inducible by Poly I:C after 7 – 24 h in a 
semiquantitative RT-PCR. These studies are performed in different salmonid cell-lines, 
offering an explanation for the discrepancy of the results upon the same stimulation. Data 
presented in this thesis (paper 3) show only a modest increase in the expression of STAT1 at 
early time-points in head kidney leukocytes, CHSE-214 and TO cells subjected to IFN-
stimulation or IPNV and ISAV infection. However STAT1 was present at a basal level at all 
times. The primers we used for the qPCR are identical to the primers used by Collet et al. 
(2007), while they differ from the primers used by Kileng et al. (2009), which are based on 
the GenBank accession no. BT045567 sequence. These expression patterns are consistent 
with a constitutively expressed STAT1 which is activated upon certain stimuli, and 
secondarily up-regulated in a positive feedback loop.  
Regulation of STAT1 activation 
We show in paper 3 that salmon STAT1 is tyrosine phosphorylated in response to IFN 
stimulation. In addition there are diverse posttranslational modifications occurring in STAT 
proteins in mammals; serine phosphorylation (Varinou et al., 2003), acetylation (DNA 
association and transcriptional activation), methylation (transcriptional activation) (Altschuler 
et al., 1999; Mowen et al., 2001), ISGylation (ISG15 conjugates to JAK1 and STAT1 and acts 
as a positive regulator of IFN signaling) (Malakhova et al., 2003) and SUMOylation (small 
ubiquitin-related modifier covalently linked to STAT1 by PIAS E3 ligase, acts negative on 
transcriptional activation) (Ungureanu et al., 2003). None of these are yet described in fish. 
Tyrosine phosphatases are important in order to dephosphorylate STATs and attenuate the 
signal transduction after the transient STAT activation. SH2-containing phosphatates can act 
in the cytoplasm by dephosphorylating phosphotyrosines on molecules docked to the IFNAR 
or JAK, and thereby limit signal transduction in an early phase (David et al., 1995). PIAS 
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(protein inhibitor of activated STAT1) proteins are constitutively expressed nuclear proteins 
that interacts with activated STAT1 and suppresses the DNA-binding ability. Thus, these 
molecules block STATs from acting as transcriptional activators at their target promoter 
sequences (Liu et al., 1998; Liu et al., 2004). Other inhibitors of cytokine signaling have been 
described, such as suppressor of cytokine signaling (SOCS) that associate with 
IFNAR/IFNGR or JAKs and target signaling proteins for ubiquitin/proteasome-mediated 
degradation (Alexander et al., 1999; Marine et al., 1999). 
As many as 11 type I IFN genes, whereof many encode similar IFNs, have recently been 
identified in salmon (Sun et al., 2009). It is speculated whether the evolution of multiple IFN 
genes and the need for such massive IFN production is coupled to the salmon being an 
anadromous species which is exposed to a greater diversity of viruses in multiple 
environments. What do many different IFNs mean for the diversity and specificity of STAT 
signaling? The specificity of STAT activation is likely to arise from specific interaction 
between STATs' SH2 domains and the receptor’s phosphotyrosine motifs rather than being 
determined by the activated JAKs. Therby, a certain level of specificity of cytokine action is 
allowed. The different kinases involved in this pathway can substitute for each other (Strobl et 
al., 2001). The different cytokines seem to have preferences as to which STAT they activate.  
One exception is IL-6 which normally activates STAT3 in mice, but in STAT3 knockout mice 
is able to activate STAT1 and trigger the typical IFNγ-inducible genes, showing cross-
regulation among STATs. In normal cells a STAT3-dependent mechanism would down-
regulate levels of STAT1 expression (Costa-Pereira et al., 2002). The specificity of the signal 
in cases where multiple cytokines activate common STATs must be determined by the 
cellular context and the specificity in the binding to the promoter-elements and co-activators. 
STAT1(-/-) mice are extremely susceptible to viral disease and cells and tissues from these 
mice are unresponsive to IFN, but remain responsive to other cytokines. Thus, STAT1 
appears to be specific for IFN pathways (Durbin et al., 1996) and has less aptitude to cross-
regulation than STAT3. 
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Future directions 
• Screening of Y2H library from immune-stimulated Atlantic salmon leukocytes with IPNV 
proteins 
• Functional studies of STAT2  and further functional studies of STAT1 in response to 
IPNV 
• Studies of the promoter elements of salmon ISGs – Are they binding STAT? 
• Utilize inhibitors of JAK/STAT signaling to pinpoint interference with IPNV 
• Explore RNA-binding properties of VP3 – importance in IFN induction/signaling and 
viral propagation. 
 
Further elucidation of these issues will extend the knowledge of virus-host interaction in fish 
at molecular levels. Emerging results from high throughput genomic-scale techniques, such as 
microarrays and proteomics in combination with bioinformatics can be extensively used to 
discover and analyze components of pathways, targets and strategies of the immune system. 
Such knowledge can eventually be used in the development of vaccines, medicine and 
prophylactic strategies to combat virus infections in farmed fish. 
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Main conclusions 
Viral protein interactions 
• IPNV VP3 is a key organizer in the viral particle as it has multiple interaction partners: 
VP3, VP1 and ds RNA.  
• VP3 binding to dsRNA is sequence-independent.  
• The binding between VP3 and VP1 is independent on the presence of dsRNA.  
• VP1-VP3 complexes occur prior to the formation of mature virions indicating a prime role 
in the assembly process.  
Antiviral effect of IFN 
• Type I IFN-treatment prior to IPNV infection induces an antiviral state wherein viral 
protein synthesis halts and VP2 maturation is inhibited. 
Viral IFN antagonism  
• The IPNV has evolved strategies to evade host immune responses.  
• Infection with IPNV prior to IFN-treatment gives higher viral titers, faster viral protein 
synthesis and reduced expression of antiviral genes. 
• VP4 and VP5 are potential candidates involved in down-regulation of IFN-signaling in the 
JAK/STAT pathway 
Salmon STAT1 
• A functional isoform of STAT1 from Atlantic salmon (ssSTAT1a) has been cloned. 
• ssSTAT1a interacts with itself. 
• ssSTAT1a is phosphorylated upon stimulation with type I and type II IFNs. 
• Salmon STAT1 translocates to the nucleus within 1 hour upon IFNγ stimulation in certain 
cell-types. 
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